JIANGSU HENGRUI PHARMACEUTICALS <600276.SS> SAYS ITS SHR-4375 INJECTION FOR PANCREATIC CANCER GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA

Reuters · 1d ago

Please log in to view news